Tigecycline: a first in class glycylcycline

This publication has 18 references indexed in Scilit:

• Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
  International Journal of Antimicrobial Agents, 2004
• Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA
  Journal of Antimicrobial Chemotherapy, 2004
• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003
  American Journal of Infection Control, 2003
• Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria
  Antimicrobial Agents and Chemotherapy, 2002
• Susceptibilities of Mycoplasma hominis, M. pneumoniae , and Ureaplasma urealyticum to GAR-936, Dalfopristin, Dirithromycin, Evernimicin, Gatifloxacin, Linezolid, Moxifloxacin, Quinupristin-Dalfopristin, and Telithromycin Compared to Their Susceptibilities to Reference Macrolides, Tetracyclines, and Quinolones
  Antimicrobial Agents and Chemotherapy, 2001
• The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit
  Cell, 2000
• In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis
  International Journal of Antimicrobial Agents, 2000
• Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant Pneumococci
  Antimicrobial Agents and Chemotherapy, 2000
• Disk diffusion susceptibility test development for the new glycylcycline, GAR-936
  Diagnostic Microbiology and Infectious Disease, 1999
• In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)
  Antimicrobial Agents and Chemotherapy, 1999